Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

Press releases published on June 16, 2026

Jun. 16, 2026

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Indeterminate GlobeNewswire

Jun. 16, 2026

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Indeterminate GlobeNewswire

Jun. 16, 2026

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Indeterminate GlobeNewswire

Jun. 16, 2026

NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure

Indeterminate GlobeNewswire

Jun. 16, 2026

CDT Equity Announces Debt Update and New Loan Facility

Indeterminate GlobeNewswire

Jun. 16, 2026

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Indeterminate GlobeNewswire

Jun. 16, 2026

King Faisal Specialist Hospital Presents Robotic Surgery as a Model for Innovation-Driven Specialized Care at HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Das King Faisal Specialist Hospital präsentiert auf der HLTH Europe 2026 die Roboterchirurgie als Vorbild für innovationsgetriebene Spezialversorgung

Indeterminate GlobeNewswire

Jun. 16, 2026

Le King Faisal Specialist Hospital présente la chirurgie robotique comme modèle de soins spécialisés axés sur l’innovation lors du congrès HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Through the MUHC Foundation, one family helps fuel breakthrough in rare cancer research

Indeterminate GlobeNewswire

Jun. 16, 2026

Une famille soutient la recherche sur les cancers rares par l’intermédiaire de la Fondation du CUSM

Indeterminate GlobeNewswire

Jun. 16, 2026

ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome

Indeterminate GlobeNewswire

Jun. 16, 2026

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Indeterminate GlobeNewswire

Jun. 16, 2026

Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium

Indeterminate GlobeNewswire

Jun. 16, 2026

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

Indeterminate GlobeNewswire

Jun. 16, 2026

Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Indeterminate GlobeNewswire

Jun. 16, 2026

MultiValent Biotherapies Launches with $27 Million Series A Financing to Advance Development of Targeted Prostate Cancer Drug Conjugate

Indeterminate GlobeNewswire

Jun. 16, 2026

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

Indeterminate GlobeNewswire

Jun. 16, 2026

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Indeterminate GlobeNewswire

Jun. 16, 2026

Sanuwave Health Updates Second Quarter 2026 Guidance

Indeterminate GlobeNewswire